EcoGenome
Wynnewood, US · Founded 2021 · Pennsylvania LLC
Find your way into EcoGenome
Each arrow is one introduction. Sign up to fill in the first one.
Ask Michael J. Sofia to introduce you to Richard G Pestell
You →Michael · together at BARUCH S BLUMBERG INSTITUTE →Richard
Sign up to find every way you can get introduced to EcoGenome
- Your email: who you already know at EcoGenome, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the EcoGenome team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Ecogenome performs molecular genetic testing of individual patients' tumors to identify therapeutic vulnerabilities and guide cancer therapy planning. The company focuses on the molecular genetics of treatment-resistant cancers.
Founders & leadership
EcoGenome was founded in 2021 by Richard G Pestell.

Reported raises · per SEC filings
Form D private placements$2M disclosed across 1 round · 2022
▶$2MraisedNov 2022 · 10 investors · BiotechnologyRule 506(b)
- Richard G PestellExecutive Officer
- Mark WallerDirector
- Offering amount
- $2.5M
- Amount sold
- $2M
- First sale
- May 2022
- Incorporated
- Limited Liability Company, Pennsylvania, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does EcoGenome do?
- Ecogenome performs molecular genetic testing of individual patients' tumors to identify therapeutic vulnerabilities and guide cancer therapy planning. The company focuses on the molecular genetics of treatment-resistant cancers.
- Who founded EcoGenome?
- EcoGenome was founded by Richard G Pestell in 2021.
- How much funding has EcoGenome raised?
- EcoGenome has disclosed $2M raised across 1 round.
- Where is EcoGenome headquartered?
- EcoGenome is headquartered in Wynnewood, US.
